Oncotarget

Vol 11, No 11

March 17, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 11 of Oncotarget features Figure 6, "Effects of AZD8186 in combination with anti-PD1 on syngeneic models," by Owusu-Brackett, et al.

Table of Contents

Research Papers

Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells

Quizartinib, a selective FLT3 inhibitor, maintains antileukemic activity in preclinical models of RAS-mediated midostaurin-resistant acute myeloid leukemia cells

https://doi.org/10.18632/oncotarget.27489

Tomoya Aikawa, Noriko Togashi, Koichi Iwanaga, Hiroyuki Okada, Yumi Nishiya, Shinichi Inoue, Mark J. Levis,  and Takeshi Isoyama
943-955
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway

DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway

https://doi.org/10.18632/oncotarget.27493

Caroline Dafflon, Swann Gaulis, Louise Barys, Karen Kapur, Vanessa Cornacchione, Lina Schukur, Sebastian Bergling, Elisabetta Traggiai, Selina Jansky, Leon Hellmann, Barbara Schacher Engstler, Grainne Kerr, Antoine de Weck, David A. Ruddy, Ulrike Naumann, Frédéric Stauffer, Christoph Gaul, Ying Lin, Eric Billy, Andreas Weiss, Francesco Hofmann, Moriko Ito,  and Ralph Tiedt
956-968
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss

Targeting PI3Kβ alone and in combination with chemotherapy or immunotherapy in tumors with PTEN loss

https://doi.org/10.18632/oncotarget.27503

Nicci Owusu-Brackett, Ming Zhao, Argun Akcakanat, Kurt W. Evans, Erkan Yuca, Ecaterina Ileana Dumbrava, Filip Janku,  and Funda Meric-Bernstam
969-981
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

Early prediction of resistance to tyrosine kinase inhibitors by plasma monitoring of EGFR mutations in NSCLC: a new algorithm for patient selection and personalized treatment

https://doi.org/10.18632/oncotarget.27517

Fiamma Buttitta, Lara Felicioni, Alessia Di Lorito, Alessio Cortellini, Luciana Irtelli, Davide Brocco, Pietro Di Marino, Donatella Traisci, Nicola D’Ostilio, Alessandra Di Paolo, Francesco Malorgio, Pasquale Assalone, Sonia Di Felice, Francesca Fabbri, Giovanni Cianci, Michele De Tursi,  and Antonio Marchetti
982-991
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Reviews

Acute promyelocytic leukemia (APL): a review of the literature

Acute promyelocytic leukemia (APL): a review of the literature

https://doi.org/10.18632/oncotarget.27513

Joaquin J. Jimenez, Ravinder S. Chale, Andrea C. Abad,  and Andrew V. Schally
992-1003
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Corrections

Correction: A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice

Correction: A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice

https://doi.org/10.18632/oncotarget.27473

Prakash Gangadaran, Xiu Juan Li, Ho Won Lee, Ji Min Oh, Senthilkumar Kalimuthu, Ramya Lakshmi Rajendran, Seung Hyun Son, Se Hwan Baek, Thoudam Debraj Singh, Liya Zhu, Shin Young Jeong, Sang-Woo Lee, Jaetae Lee,  and Byeong-Cheol Ahn
1004-1005
Correction  |  PDF  |  How to cite

Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations

Correction: Enhanced tumorigenicity by mitochondrial DNA mild mutations

https://doi.org/10.18632/oncotarget.27522

Alberto Cruz-Bermúdez, Carmen G. Vallejo, Ramiro J. Vicente-Blanco, María Esther Gallardo, Miguel Ángel Fernández-Moreno, Miguel Quintanilla,  and Rafael Garesse
1006-1006
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC